Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 5/20 | 0.60 |
| ▸ | LPL | P06858 | 7/20 | 0.52 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.52 |
| ▸ | F11 | P03951 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | MGLL | Q99685 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17011388 | 0.83 | ENPP2 (0.47) | ENPP2LPLLIPGF11CA2 | |
| SCHEMBL2154504 | 0.80 | KMT2A (0.47) | ENPP2KMT2A | |
| SCHEMBL15330296 | 0.78 | LPL (0.55) | ENPP2LPLLIPGF11CA2 | |
| SCHEMBL29952121 | 0.77 | LPL (0.52) | ENPP2LPLLIPGF11CA2 | |
| SCHEMBL473915 | 0.75 | ENPP2 (1.00) | ENPP2LPLLIPGMGLLKMT2A | |
| SCHEMBL4005403 | 0.73 | KMT2A (0.44) | ENPP2CA2CA1TSHRKMT2A | |
| SCHEMBL448467 | 0.73 | MMP3 (0.57) | CA2CA1KMT2ACA4CA6 | |
| SCHEMBL6708148 | 0.72 | ENPP2 (0.42) | ENPP2KMT2A | |
| SCHEMBL23137321 | 0.72 | MMP3 (0.50) | ENPP2TSHRKMT2A | |
| SCHEMBL890400 | 0.72 | LPL (0.73) | ENPP2LPLLIPGF11CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113831510-B | Covalent organic framework based on benzoselenadiazole and preparation method and application thereof | 山东师范大学 | 2024-04-16 | — | — | CN | claimed |
| CN-116375674-B | Double-state fluorescent probe for picric acid detection and preparation method thereof | 厦门大学 | 2024-03-29 | — | — | CN | claimed |
| CN-116375674-A | Double-state fluorescent probe for picric acid detection and preparation method thereof | 厦门大学 | 2023-07-04 | — | — | CN | claimed |
| CN-113527318-B | Preparation of carbon-carbon double-bond-connected covalent organic microporous material and application of material in photolysis of water | 山东师范大学 | 2022-06-21 | — | — | CN | claimed |
| CN-114085195-B | Biodegradable film material with light conversion function, preparation method thereof and film doping material thereof | 浙江播下环保科技有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-111875628-B | Fluorescent probe with aggregation-induced emission characteristic, preparation method and application | 中国药科大学 | 2022-04-08 | — | — | CN | claimed |
| CN-114085195-A | Biodegradable film material with light conversion function, preparation method thereof and film doping material thereof | 浙江播下环保科技有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-113831510-A | Covalent organic framework based on benzoselenadiazole and preparation method and application thereof | 山东师范大学 | 2021-12-24 | — | — | CN | claimed |
| CN-113527318-A | Preparation of carbon-carbon double-bond-connected covalent organic microporous material and application of material in photolysis of water | 山东师范大学 | 2021-10-22 | — | — | CN | claimed |
| CN-111875628-A | Fluorescent probe with aggregation-induced emission characteristic, preparation method and application | 中国药科大学 | 2020-11-03 | — | — | CN | claimed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-20260084134-A1 | STORAGE AND DELIVERY OF GASEOUS CHEMICAL REACTANTS IN CHEMICAL PROCESSES USING METAL-ORGANIC FRAMEWORKS | UNIV CORNELL (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4680607-A1 | BICYCLIC UREAS AS KINASE INHIBITORS | Incyte Corporation (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | GIVAUDAN SA (CH) | 2026-01-20 | — | — | US | disclosed |
| US-12473289-B2 | Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use | AMGEN INC. (US) | 2025-11-18 | — | — | US | disclosed |
| WO-2004024707-A2 | PROCESS FOR PREPARING AMINE TYPE SUBSTITUTED BENZOFURANS | ABBOTT LABORATORIES (US) | 2004-03-25 | — | — | WO | disclosed |
| US-20040054185-A1 | Process for preparing amine-substituted benzofurans | COWART MARLON D (US) | 2004-03-18 | — | — | US | disclosed |
| US-20030225266-A1 | Sulfonamide derivatives | ELI LILLY AND COMPANY | 2003-12-04 | — | — | US | disclosed |
| EP-1265857-A1 | SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001068592-A1 | SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | TRPM8, TRPM7, TRPM5 | ENPP2 4310/4885LPL 2835/4885LIPG 2646/4885 |
| US-20260084134-A1 | STORAGE AND DELIVERY OF GASEOUS CHEMICAL REACTANTS IN CHEMICAL PROCESSES USING METAL-ORGANIC FRAMEWORKS | ME3, ME2, SLC25A11 | ENPP2 4761/4885LPL 3997/4885LIPG 2991/4885 |
| US-20030225266-A1 | Sulfonamide derivatives | GRIN2A, GRM2, GRIA2 | ENPP2 820/4885LPL 4820/4885LIPG 4826/4885 |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | TRPM8, TRPM7, TRPM4 | ENPP2 4166/4885LPL 2903/4885LIPG 3062/4885 |
| US-12473289-B2 | Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use | SCD5, SCD, FADS2 | ENPP2 878/4885LPL 152/4885LIPG 205/4885 |
| US-20040054185-A1 | Process for preparing amine-substituted benzofurans | HRH4, HRH2, HRH3 | ENPP2 2020/4885LPL 4839/4885LIPG 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.